Hikma Pharmaceuticals allowed to conduct due diligence on GSK Egypt
Cairo – Mubasher: The board of directors of Glaxo SmithKline (GSK Egypt) agreed to allow Hikma Pharmaceuticals Plc to conduct due diligence on the company, according to a bourse disclosure on Wednesday. On Tuesday, the company said that its …